Skip to main content
LFVN logo

LifeVantage Corporation (LFVN) Stock Price & Analysis

LifeVantage Corporation (LFVN) — MoonshotScore 61/100 (Fair band), calculated Nov 18, 2026. Price $4.15 (-15.13%), as of the Nov 20, 2026 trading session; market cap $52.6M.

Educational signal · not a buy or sell recommendation · How to read this

$4.15 −$0.74 (-15.13%) Market Cap $52.6M

LifeVantage Corporation · LFVN · NASDAQ

LifeVantage Corporation develops and distributes nutrigenomic activators, dietary supplements, and skincare products through a network of independent distributors and its website. The company operates in multiple international markets, including the United States, Mexico, Japan, and several European countries.

Price as of Nov 20, 2026

Key Statistics

61 of 100

MoonshotScore v2 · LifeVantage (LFVN)

Fair
Business Quality Elite (81)
Financial Safety Okay (42)
Valuation Cheap (93)
Growth Durability Shrinking (13)
Momentum Slipping (30)
Why this rating? Method, drivers & history

Bands for the MoonshotScore: Exceptional 80-100 · Strong 65-79 · Fair 45-64 · Weak below 45.

  • Business Quality — Is this a genuinely good business?
  • Financial Safety — Could this blow up on me?
  • Valuation — Am I paying a fair price?
  • Growth Durability — Is the growth real and likely to last?
  • Momentum — Is the market already moving on this?
The ten-second read ·

High quality, at a dirt-cheap price, but stalling growth. Business Quality: Elite; Financial Safety: Okay; Valuation: Cheap; Growth Durability: Shrinking; Momentum: Slipping.

  • quarterly revenue $48M (Q1 FY2026, quarter ended Sep 2025)
  • EPS beat 0 of the last 4 reports
  • Altman Z 2.38 · Piotroski F 4

Holding back: soft growth, weak price trend

Helping: business quality, an attractive price

What has the MoonshotScore done over time?

MoonshotScore snapshots recorded for LFVN (58 recorded, newest six shown)
RecordedScoreBand
60Fair
61Fair
61Fair
61Fair
61Fair
61Fair

Daily score refresh is delayed. This is the last recorded calculation.

Calculation uses the most recent completed US trading session. Live price changes do not update the score immediately.

Computed · How the MoonshotScore is computed →

Price & valuation

Dates shown where recorded
MeasureValueAs of
Latest provided price$4.15
Change on the day-15.13%
Market capitalisation$52.6M—
Price / earnings (trailing)22.31
Shares traded on the day72.9K

Price & events

Other perspectives

Council score for LifeVantage (LFVN): perspectives

Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.

5-Factor Breakdown

Business Quality Strong
Financial Safety Neutral
Valuation Strong
Growth Durability Negative
Momentum Weak

Legends Council

6 lenses, 0 current

AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built

Dalio-style lens (simulated) Ray Dalio Favorable read
Griffin-style lens (simulated) Ken Griffin Unfavorable read
Simons-style lens (simulated) Jim Simons Neutral read
Englander-style lens (simulated) Izzy Englander Neutral read
Klarman-style lens (simulated) Seth Klarman Favorable read
Moon AI lens (model) Favorable read

Read on: Nov 17, 2026 · older than the 27 hours refresh window; not a current reading

Munger's Mindset

Balance Sheet & Valuation · historical

Financial Health Moderate
Margin of Safety Undervalued
Profit Margin Weak
Debt/Equity Moderate
ROE Neutral
Gross Margin Strong

Read on: Nov 17, 2026 · older than the 27 hours refresh window; not a current reading

How to read these bars and different assessments

Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.

Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.

On Nov 17, 2026, the Munger lens read the price at that time as undervalued against its own estimate of value.

Readings on this page are from Nov 21, 2026, except a card that shows its own read date.

1 · What is it?

What is LifeVantage (LFVN), and what does it report?

Short answer

A current FMP business description is unavailable; the listing and provider classification below are the available identity facts. LifeVantage Corporation (LFVN) is listed on NASDAQ. It employs 209 people. In Q1 FY2026 it reported revenue of $48M and net income of $2M. The market values it at $52.6M.

2 · Latest results

What do the latest results show for LifeVantage (LFVN)?

Short answer · as of

The most recent reported quarter, Q1 FY2026, carried revenue of $48M. Against analyst estimates the company has EPS beat 0 of the last 4 reports.

Quarterly income statement — 4 quarters
Revenue, net income and earnings per share by quarter
PeriodRevenueNet incomeEPS
Q1 FY2026$48M$2M$0.17 (diluted)
Q2 FY2026$49M$276,000$0.02 (diluted)
Q3 FY2026$44M$1M$0.11 (diluted)
Q4 FY2026$42M$1M$0.10 (diluted)
3 · Financial strengths and risks

What are the financial strengths and risks for LifeVantage (LFVN)?

Short answer · as of

The MoonshotScore pillars rate business quality, an attractive price as strengths. What is holding it back is soft growth, weak price trend. The distress and quality screens read Altman Z 2.38 · Piotroski F 4. Trailing ratios: ROE 8.2% · ROA 4.4% · current ratio 1.91.

4 · What to check next?

What should you watch next at LifeVantage (LFVN)?

Short answer · as of

The stored analyst-target capture is expired, so a current target watchpoint is unavailable.

What the records here don't tell us

  • No forward revenue or earnings estimate is on file.
  • The next earnings date is not yet scheduled in the calendar we read.
  • The newest quarter held here (Q1 FY2026) was filed Nov 4, 2025 — 12 months ago.

Checked against the records this page reads, on the dates shown above.

5 · Peer comparison

How does LifeVantage compare with its peers?

Short answer

LifeVantage's score ranks 5th of 13 in the bounded comparison shown, against 12 same-model peers. These are company scores, not expected investment returns. The set lists named competitors first, then companies in the same data-provider industry classification closest in market value; that classification is the provider's, not our judgment of business similarity.

Peer set — price, market value and MoonshotScore
CompanyPriceMarket valueScore
Herbalife Nutrition Ltd. (HLF) Named competitor$15.53 Nov 20, 2026$1.63B92 5-pillar Nov 18, 2026
Coffee Holding Co., Inc. (JVA) Same industry, near in market value$4.93 Nov 20, 2026$28.1M85 5-pillar Nov 18, 2026
USANA Health Sciences, Inc. (USNA) Named competitor$12.94 Nov 20, 2026$239M73 5-pillar Nov 18, 2026
FitLife Brands, Inc. (FTLF) Same industry, near in market value$6.20 Nov 20, 2026$58.2M63 5-pillar Nov 18, 2026
LifeVantage (LFVN) — this page$4.15$52.6M61
Nature's Sunshine Products, Inc. (NATR) Same industry, near in market value$10.18 Nov 20, 2026$176M43 5-pillar Nov 18, 2026
Bridgford Foods Corporation (BRID) Same industry, near in market value$5.01 Nov 20, 2026$45.5M40 5-pillar Nov 18, 2026
Lifeway Foods, Inc. (LWAY) Same industry, near in market value$19.17 Nov 20, 2026$290M39 5-pillar Nov 18, 2026
Nu Skin Enterprises, Inc. (NUS) Named competitor$3.80 Nov 20, 2026$185M35 5-pillar Nov 18, 2026
Marwynn Holdings, Inc. (MWYN) Same industry, near in market value$1.19 Nov 20, 2026$28.8M34 5-pillar Nov 18, 2026
BRC Inc. (BRCC) Same industry, near in market value$7.21 Nov 20, 2026$181M34 5-pillar Nov 18, 2026
Laird Superfood, Inc. (LSF) Same industry, near in market value$2.15 Nov 20, 2026$24.2M33 5-pillar Nov 18, 2026
Sow Good Inc. (SOWG) Same industry, near in market value$2.37 Nov 20, 2026$47.6M28 5-pillar Nov 18, 2026

Only 5-pillar scores are ranked together. Other models are not directly comparable. Price and score dates are shown separately; market-value dates are unavailable.

The records behind this page

Analyst targets & estimates

What analysts have on file

Last captured analyst target range, low to high (expired, captured Nov 18, 2026)
$6.00 – $8.00
Last captured analyst target (expired, captured Nov 18, 2026)
$7.00
Last captured median analyst target (expired, captured Nov 18, 2026)
$7.00

Historical target record · Captured · Capture expired; not a current watchpoint.

Insider activity

Form 4 records via FMP · Of the newest 100 records, those within the last 180 days, newest dated Nov 5, 2026

Transactions
25
Identified insiders
9
Purchases
2
Sales
3
Other transactions
20

Purchases and sales use the reported transaction category. Other transactions include awards, exercises, gifts, withholding and unclassified activity; an acquisition or disposition alone is not a purchase or sale. These records do not establish intent.

Who holds the shares?

Institutional ownership reported through 13F filings.

Tracked investors

Which of the 16 named investors we follow held LFVN in their latest 13F filing, and what they did against the filing before it.

None of the 16 tracked investors reported LFVN in their latest 13F filing.

See all tracked investor portfolios

How to read these figures

These filings arrive after the quarter ends. Names appear as the provider lists them, not as a verified ranking, and without filing dates. Related managers can appear separately, so their shares are not added together. Tracked investors: each fund's own latest 13F, so funds that have not filed the newest quarter yet show their previous one; weight is the share of the fund's reported 13F value.

What has been published about LifeVantage (LFVN)?

Read these with our analysis →

Investor Questions: LFVN Stock

These answers are editorial: 1 of these 9 answers is drawn from the LFVN research dossier (written May 10, 2026 by gemini-2.0-flash); the other 8 are question templates that restate figures shown above. Figures in this section are not part of the source register.

What does the MoonshotScore mean for LFVN?

LFVN carries the MoonshotScore stated above — the Fair band. This is an educational research signal, not a buy or sell recommendation. The number comes from the five-pillar engine (business quality, financial safety, valuation, growth durability, momentum), re-ranked daily against sector peers.

Is LFVN a good stock to buy?

Stock Expert AI does not rate LFVN buy, sell or hold. LifeVantage Corporation carries a MoonshotScore, in the Fair band, a research rating against its peers rather than a forecast. Whether it fits is your call: check what it sells, whether it earns and what the price assumes. This is educational content, not investment advice.

What is the LFVN stock price today?

The last price recorded for LifeVantage Corporation (LFVN), with its trading session and source, is listed under Price & valuation on this page. It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.

What is the LFVN price target?

The last analyst consensus price target we captured for LifeVantage Corporation (LFVN), with its FMP capture date, is listed under Analyst targets & estimates on this page. That capture has expired, so read it as historical, not as a current target. Targets are analyst opinions, not a Stock Expert AI forecast.

What do analysts say about LFVN stock?

Analyst coverage of LifeVantage Corporation (LFVN) is limited, reflecting its small-cap status. Key valuation metrics to consider include its P/E ratio, gross margin, and dividend yield.

What are the key factors to evaluate for LFVN?

LifeVantage Corporation (LFVN) holds a MoonshotScore in the moderate range. To weigh it, start with the trailing P/E under Price & valuation on this page. Focusing on specific health concerns, such as cognitive function, immune support, and healthy aging, can attract new customer segments. Not financial advice.

How frequently does LFVN data refresh on this page?

LFVN's price is the last quote we recorded, from the Nov 20, 2026 trading session. Pages are served from a cache, so the copy you are reading can lag that quote. The quote is a provider snapshot, not an exchange feed. Fundamentals follow quarterly filings. V2 is recalculated from the most recent completed US trading session; the score's own date shows its last successful run.

What has driven LFVN's recent stock price performance?

LifeVantage Corporation (LFVN) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Proprietary nutrigenomic technology and patented formulations. See the News tab for the latest drivers. Past performance does not predict future results.

Should investors consider LFVN overvalued or undervalued right now?

The trailing P/E of LifeVantage Corporation (LFVN) is listed under Price & valuation on this page. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.

Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated May 10, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.

Sources: the source register lists the 18 figures on this page — 15 from Financial Modeling Prep (FMP), 2 with no recorded source and 1 from Stock Expert AI's own score and rank. Its rows (value as shown, as-of date, tier and source link) are in the Markdown version of this page.

Publication details and research sources
Published
Research standards
Methodology · Editorial policy · Corrections
Data Sources & Methodology
Figures come from Financial Modeling Prep (FMP). If FMP has no figure for a ticker, a price or fundamental may come from a Yahoo Finance fallback, or a price from an Alpaca fallback. SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.